| 0 (0%) | 12-05 10:02 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 108.01 | 1-year : | 126.16 |
| Resists | First : | 92.48 | Second : | 108.01 |
| Pivot price | 87.27  |
|||
| Supports | First : | 72.1 | Second : | 59.5 |
| MAs | MA(5) : | 88.85  |
MA(20) : | 86.65 |
| MA(100) : | 64.15 |
MA(250) : | 0 | |
| MACD | MACD : | 5.5 |
Signal : | 6.1 |
| %K %D | K(14,3) : | 64.8 |
D(3) : | 66 |
| RSI | RSI(14): 71 |
|||
| 52-week | High : | 94.93 | Low : | 51.79 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GMED ] has closed below upper band by 36.0%. Bollinger Bands are 0.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 89.26 - 89.85 | 89.85 - 90.38 |
| Low: | 85.83 - 86.59 | 86.59 - 87.27 |
| Close: | 87.57 - 88.76 | 88.76 - 89.84 |
Fri, 05 Dec 2025
Norges Bank Purchases Shares of 1,152,793 Globus Medical, Inc. $GMED - MarketBeat
Fri, 05 Dec 2025
How robust is GMED stock financial position - Wall Street Watch & Accurate Entry/Exit Alerts - Newser
Thu, 04 Dec 2025
Insider Selling: Globus Medical (NYSE:GMED) CFO Sells 18,542 Shares of Stock - MarketBeat
Thu, 04 Dec 2025
Will GMED stock keep high P E multiples - 2025 Short Interest & Accurate Buy Signal Notifications - Newser
Thu, 04 Dec 2025
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term - Yahoo Finance
Wed, 03 Dec 2025
Insider Sale: Senior Vice President of $GMED Sells 18,542 Shares - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 111 (M) |
| Shares Float | 111 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 108.6 (%) |
| Shares Short | 4,820 (K) |
| Shares Short P.Month | 6,330 (K) |
| EPS | 3.08 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 32.68 |
| Profit Margin | 15.3 % |
| Operating Margin | 22.2 % |
| Return on Assets (ttm) | 6.4 % |
| Return on Equity (ttm) | 10 % |
| Qtrly Rev. Growth | 22.8 % |
| Gross Profit (p.s.) | 16.78 |
| Sales Per Share | 24.86 |
| EBITDA (p.s.) | 7.17 |
| Qtrly Earnings Growth | 131.6 % |
| Operating Cash Flow | 715 (M) |
| Levered Free Cash Flow | 446 (M) |
| PE Ratio | 28.78 |
| PEG Ratio | 0 |
| Price to Book value | 2.72 |
| Price to Sales | 3.57 |
| Price to Cash Flow | 13.85 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|